The team at Oxford University behind the landmark RECOVERY trial of COVID-19 therapies now has monkeypox in its sights, with a study that will see if Siga Technologies' smallpox drug Tpoxx
The EMA's Emergency Task Force (ETF) has recommended that EU member states can use a different regimen for Bavarian Nordic's monkeypox vaccine Imvanex/Jynneos that uses a smaller dose, to e
With monkeypox now officially declared a public health emergency in the US, digital health company Get Well has developed a management plan to track people infected with monkeypox and help
Monkeypox has claimed the first lives outside Africa – one in Brazil and another two in Spain – although the World Health organization (WHO) has said the outbreak remains "containable."
The EMA has extended the approved indications of Bavarian Nordic's smallpox vaccine Imvanex for monkeypox, which has now infected tens of thousands of people across dozens of countries worl
The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from P
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.
